A therapeutic HPV vaccine could eliminate precancerous cervical lesions
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published in Clinical Cancer…
Risk reduction from HPV vaccination goes beyond cervical cancer #ASCO24
Results from a new study suggest that the human papillomavirus (HPV) vaccine is effective in preventing the development of several types of cancers caused by HPV, most particularly head and…
Tumori: cresce la paura ma non decolla la prevenzione. Rapporto del Censis
Nel 2022 in Italia si sono registrati 2.479 nuovi casi di tumore della cervice uterina causati dal Papillomavirus. Il tumore al collo dell’utero rappresenta ancora una importante causa di morte…